you are here: HomeNewsBiocon
biocon
Jump to
1508 Results Found
  • Biocon to set up R&D unit in Telangana Feb 23, 2018 10:17 PM IST

    Biocon to set up R&D unit in Telangana

    The company will also be expanding its current presence in Hyderabad on APIs (Active Pharmaceutical Ingredients/ Intermediates) to add 500 new jobs.

  • Buy Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan, Motherson Sumi: Ashwani Gujral Feb 22, 2018 01:34 PM IST

    Buy Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan, Motherson Sumi: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Indiabulls Housing Finance, Motilal Oswal, Biocon, Titan Company an Motherson Sumi Systems.

  • Buy Biocon, TCS; sell Hindalco Industries: Rajat Bose Feb 22, 2018 11:00 AM IST

    Buy Biocon, TCS; sell Hindalco Industries: Rajat Bose

    Rajat Bose of rajatkbose.com is of the view that one can buy Biocon and TCS and can sell Hindalco Industries.

  • Sell Raymond, Titan Company; buy Biocon: Ashwani Gujral Feb 16, 2018 01:36 PM IST

    Sell Raymond, Titan Company; buy Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can sell Raymond and Titan Company and can buy Biocon.

  • Buy Biocon, Ajanta Pharma, Ashok Leyland: Rajat Bose Feb 08, 2018 02:28 PM IST

    Buy Biocon, Ajanta Pharma, Ashok Leyland: Rajat Bose

    Rajat Bose of rajatkbose.com recommends buying Biocon, Ajanta Pharma and Ashok Leyland.

  • Sell ONGC, SRF, Marico;  buy Biocon, DLF: Sudarshan Sukhani Feb 06, 2018 10:23 AM IST

    Sell ONGC, SRF, Marico; buy Biocon, DLF: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com suggests selling ONGC, SRF and Marico.

  • Sensex, Nifty crack over 1% as markets bleed further, 127 stocks hit new 52-week low; IT trades in green Feb 05, 2018 10:04 AM IST

    Sensex, Nifty crack over 1% as markets bleed further, 127 stocks hit new 52-week low; IT trades in green

    The market breadth was in favour of the declines on Monday morning with 120 stocks advancing while 1532 stocks declined and 382 stocks remained unchanged. On the BSE, 266 stocks advanced while 1960 stocks declined and 79 remained unchanged.

  • Buy Bajaj Auto, Biocon; sell Canara Bank, Chennai Petro: Sudarshan Sukhani Feb 02, 2018 11:26 AM IST

    Buy Bajaj Auto, Biocon; sell Canara Bank, Chennai Petro: Sudarshan Sukhani

    Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bajaj Auto and Biocon and can sell Canara Bank and Chennai Petro.

  • Europe drug regulator's panel gives thumbs-up to Biocon's insulin glargine Jan 29, 2018 07:45 PM IST

    Europe drug regulator's panel gives thumbs-up to Biocon's insulin glargine

    The CHMP positive opinion will be considered by the European Commission which is expected to decide on approval in April this year.

  • Biocon pins hopes on emerging markets to deliver in FY19 Jan 29, 2018 07:26 PM IST

    Biocon pins hopes on emerging markets to deliver in FY19

    The company said the growth in the coming quarters will be boosted by two key approvals it received for its long acting insulin glargine in Russia and cancer biosimilar Trastuzumab from Brazilian regulatory authorities.

  • Kiran Mazumdar-Shaw, Rajiv Lall appointed to USIBC board Jan 26, 2018 07:45 PM IST

    Kiran Mazumdar-Shaw, Rajiv Lall appointed to USIBC board

    In a statement, the USIBC said it will work to advance the US-India strategic and economic relationship by advocating for policy changes that can unlock greater growth and investment opportunities for businesses

  • Biologics biz a large value unlocking opportunity; see revival from Q4: Biocon Jan 25, 2018 12:57 PM IST

    Biologics biz a large value unlocking opportunity; see revival from Q4: Biocon

    We are going to expand our biosimilars pipeline both with Mylan and Sandoz and beyond on our own, said Kiran Mazumdar Shaw, CMD, Biocon.

  • Market Update: L&T, ONGC, Vedanta hit record highs despite broader indices trading flat; SBI falls 2% Jan 25, 2018 10:04 AM IST

    Market Update: L&T, ONGC, Vedanta hit record highs despite broader indices trading flat; SBI falls 2%

    The market breadth was in favour of the advances on Thursday morning with 804 stocks advancing as against 782 declines while 418 remained unchanged. On the other hand, 1051 stocks advanced and 948 stocks declined while 85 remained unchanged on the BSE.

  • Biocon profits fall 46% in Q3 as sales remain flat, interest & depreciation costs weigh Jan 24, 2018 08:33 PM IST

    Biocon profits fall 46% in Q3 as sales remain flat, interest & depreciation costs weigh

    The company said the “operating margins declined on account of lower licensing income, compounded by fixed and operating costs related to Malaysia operations.”

  • Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl Jan 24, 2018 02:19 PM IST

    Focus on growth, investments; capacity in Biologics a growth driver: Syngene Intl

    EBITDA Margins around 31-33% with focus on growth and investments are good, said Jonathan Hunt, CEO of Syngene International.

  • Glenmark Pharma, Biocon, Dr Reddy's Labs, Sun Pharma, Lupin to get astrological support: Satish Gupta Jan 24, 2018 12:18 PM IST

    Glenmark Pharma, Biocon, Dr Reddy's Labs, Sun Pharma, Lupin to get astrological support: Satish Gupta

    Glenmark Pharma, Biocon, Dr Reddy's Labs, Sun Pharma and Lupin will get astrological support, says Satish Gupta of astrostocktips.

  • Market Update: CNX IT outperforms as TCS hits new 52-week high; GAIL top gainer, Bharti Airtel falls 4% Jan 24, 2018 10:02 AM IST

    Market Update: CNX IT outperforms as TCS hits new 52-week high; GAIL top gainer, Bharti Airtel falls 4%

    The market breadth was in favour of the declines on Wednesday morning with 384 stocks advancing as against 1220 declines while 405 remained unchanged. On the other hand, 673 stocks advanced and 1463 stocks declined while 87 remained unchanged on the BSE.

  • Market Update: Nifty tops 11K mark as Infosys, RIL hit new 52-week high; Axis Bank most active Jan 23, 2018 09:57 AM IST

    Market Update: Nifty tops 11K mark as Infosys, RIL hit new 52-week high; Axis Bank most active

    The market breadth was in favour of the advances on Tuesday morning with 1047 stocks advancing as against 541 declines while 419 remained unchanged. On the other hand, 1292 stocks advanced and 701 stocks declined while 78 remained unchanged on the BSE.

  • Buy Yes Bank, Indiabulls Housing, ICICI Prudential, Biocon: Ashwani Gujral Jan 20, 2018 02:24 PM IST

    Buy Yes Bank, Indiabulls Housing, ICICI Prudential, Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Yes Bank, Indiabulls Housing, ICICI Prudential and Biocon.

  • Biocon CEO Arun Chandavarkar says Sandoz tie-up to help them target multi-billion dollar biosimilar opportunity Jan 19, 2018 03:01 PM IST

    Biocon CEO Arun Chandavarkar says Sandoz tie-up to help them target multi-billion dollar biosimilar opportunity

    These biosimilars are in early stages of development. As the cost incurred during the early stages are not significant we don’t expect our R&D costs to go up materially as of now.

  • Partnership with Sandoz is for the future wave of biosimilars: Biocon Jan 19, 2018 12:28 PM IST

    Partnership with Sandoz is for the future wave of biosimilars: Biocon

    The company is trying to combine forces with companies who have been successful in biosimilars, said Kiran Mazumdar Shaw, CMD, Biocon.

  • Biocon gains 4% on global partnership with Sandoz for biosimilars in immunology, oncology Jan 19, 2018 11:00 AM IST

    Biocon gains 4% on global partnership with Sandoz for biosimilars in immunology, oncology

    Sandoz will lead commercialisation in North America and the European Union, while Biocon will lead commercialisation in the rest of the world.

  • Buy Glenmark Pharma, Jain Irrigation Systems; sell Biocon: Ashwani Gujral Jan 10, 2018 11:19 AM IST

    Buy Glenmark Pharma, Jain Irrigation Systems; sell Biocon: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com is of the view that one can buy Glenmark Pharma and Jain Irrigation Systems and can sell Biocon.

  • Market Update: 187 stocks hit 52-week high on NSE; Philips Carbon zooms 17%, JSPL, Sun Pharma most active Jan 08, 2018 02:30 PM IST

    Market Update: 187 stocks hit 52-week high on NSE; Philips Carbon zooms 17%, JSPL, Sun Pharma most active

    The market breadth was in favour of the advances on Monday afternoon with 1065 stocks advancing as against 665 declines while 291 remained unchanged. On the other hand, 1801 stocks advanced and 1121 stocks declined while 116 remained unchanged on the BSE.

  • Market Update: CNX Pharma outshines as Sun Pharma jumps 3%; L&T, Tech Mahindra hits 52-week high, JSPL up 8% Jan 08, 2018 10:05 AM IST

    Market Update: CNX Pharma outshines as Sun Pharma jumps 3%; L&T, Tech Mahindra hits 52-week high, JSPL up 8%

    The market breadth was in favour of the advances on Monday morning with 1161 stocks advancing as against 467 declines while 386 remained unchanged. On the other hand, 1633 stocks advanced and 676 stocks declined while 88 remained unchanged on the BSE.

Sections